Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NexLife is a South Korean medical device company specializing in the development and manufacturing of advanced diagnostic systems, with a primary focus on diabetes management. The company is best known for its GlucoNavii brand, which includes a range of blood glucose monitoring systems designed for both professional and personal use. NexLife leverages biosensor technology to provide high-accuracy testing solutions that facilitate effective chronic disease management. As a subsidiary of SD Biosensor, the company benefits from extensive R&D resources and a global distribution network, positioning it as a key player in the international point-of-care testing market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NexLife.